| Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements EM Agger, I Rosenkrands, J Hansen, K Brahimi, BS Vandahl, C Aagaard, ... PloS one 3 (9), e3116, 2008 | 345 | 2008 |
| Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3 C Roussilhon, C Oeuvray, C Müller-Graf, A Tall, C Rogier, JF Trape, ... PLoS medicine 4 (11), e320, 2007 | 294 | 2007 |
| Antigenic Equivalence of Human T-Cell Responses toMycobacterium tuberculosis-Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 … SM Arend, A Geluk, KE van Meijgaarden, JT van Dissel, M Theisen, ... Infection and immunity 68 (6), 3314-3321, 2000 | 254 | 2000 |
| Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies MF Muellenbeck, B Ueberheide, B Amulic, A Epp, D Fenyo, CE Busse, ... Journal of Experimental Medicine 210 (2), 389-399, 2013 | 244 | 2013 |
| Cytophilic Immunoglobulin Responses to Plasmodium falciparum Glutamate-Rich Protein Are Correlated with Protection against Clinical Malaria in Dielmo, Senegal C Oeuvray, M Theisen, C Rogier, JF Trape, S Jepsen, P Druilhe Infection and immunity 68 (5), 2617-2620, 2000 | 225 | 2000 |
| Epitope Mapping of the Immunodominant Antigen TB10.4 and the Two Homologous Proteins TB10.3 and TB12.9, Which Constitute a Subfamily of the esat-6 Gene … RLV Skjøt, I Brock, SM Arend, ME Munk, M Theisen, THM Ottenhoff, ... Infection and immunity 70 (10), 5446-5453, 2002 | 217 | 2002 |
| Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal … I Nebie, A Diarra, A Ouedraogo, I Soulama, EC Bougouma, AB Tiono, ... Infection and immunity 76 (2), 759-766, 2008 | 215 | 2008 |
| Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses … S Soe, M Theisen, C Roussilhon, KS Aye, P Druilhe Infection and immunity 72 (1), 247-252, 2004 | 211 | 2004 |
| Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children D Dodoo, A Aikins, KA Kusi, H Lamptey, E Remarque, P Milligan, ... Malaria journal 7, 1-11, 2008 | 198 | 2008 |
| The Glutamate-Rich Protein (GLURP) of Plasmodium falciparum Is a Target for Antibody-Dependent Monocyte-Mediated Inhibition of Parasite Growth In Vitro M Theisen, S Soe, C Oeuvray, AW Thomas, J Vuust, S Danielsen, ... Infection and immunity 66 (1), 11-17, 1998 | 190 | 1998 |
| Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli M Theisen, J Vuust, A Gottschau, S Jepsen, B Høgh Clinical Diagnostic Laboratory Immunology 2 (1), 30-34, 1995 | 175 | 1995 |
| Naturally Acquired Antibodies to the Glutamate-Rich Protein Are Associated with Protection against Plasmodium falciparum Malaria D Dodoo, M Theisen, JAL Kurtzhals, BD Akanmori, KA Koram, S Jepsen, ... The Journal of infectious diseases 181 (3), 1202-1205, 2000 | 163 | 2000 |
| Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen M Theisen, B Frederiksen, AM Lebech, J Vuust, K Hansen Journal of clinical microbiology 31 (10), 2570-2576, 1993 | 161 | 1993 |
| Safety and immunogenicity of GMZ2—a MSP3–GLURP fusion protein malaria vaccine candidate M Esen, PG Kremsner, R Schleucher, M Gässler, EB Imoukhuede, ... Vaccine 27 (49), 6862-6868, 2009 | 160 | 2009 |
| Recent advances in recombinant protein-based malaria vaccines SJ Draper, E Angov, T Horii, LH Miller, P Srinivasan, M Theisen, S Biswas Vaccine 33 (52), 7433-7443, 2015 | 150 | 2015 |
| Analysis of the OspE Determinants Involved in Binding of Factor H and OspE-Targeting Antibodies Elicited during Borreliaburgdorferi Infection in Mice MS Metts, JV McDowell, M Theisen, PR Hansen, RT Marconi Infection and immunity 71 (6), 3587-3596, 2003 | 146 | 2003 |
| Identification and Characterization of a 29-Kilodalton Protein from Mycobacterium tuberculosis Culture Filtrate Recognized by Mouse Memory Effector Cells I Rosenkrands, PB Rasmussen, M Carnio, S Jacobsen, M Theisen, ... Infection and immunity 66 (6), 2728-2735, 1998 | 136 | 1998 |
| Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial CC Hermsen, DF Verhage, DSC Telgt, K Teelen, JT Bousema, ... Vaccine 25 (15), 2930-2940, 2007 | 134 | 2007 |
| A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children SB Sirima, B Mordmüller, P Milligan, UA Ngoa, F Kironde, F Atuguba, ... Vaccine 34 (38), 4536-4542, 2016 | 133 | 2016 |
| A Plasmodium falciparum GLURP–MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies M Theisen, S Soe, K Brunstedt, F Follmann, L Bredmose, H Israelsen, ... Vaccine 22 (9-10), 1188-1198, 2004 | 131 | 2004 |
